EQA Scheme
Contact
Virus Antigen Detection - Panel for the Detection of Influenza A/B Viruses, RSV and SARS-CoV-2 (Ag) (410)
Samples:
5 samples of 0.5 ml
Sample properties:
Liquid cell culture material (inactivated)
Additional Information:
Note: When performing tests using your own swab, please note that the provided sample volume of 0.5 ml is generally sufficient for performing
one SARS-CoV-2 test, one influenza virus test, and one RSV test. However, depending on the absorbency of the swab used, a second tube may be necessary.
For POCT systems: Please ensure that the sample matrix used in the EQA scheme is suitable for your test system. In case of uncertainty, we recommend contacting the manufacturer or supplier of your device.
Cooperation with:
Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité - Universitätsmedizin Berlin;
Requirement for EQAS/PT according to Rili-BÄK
Parameters:
Detection of influenza A/B antigen and RSV antigen
Certificate Validity: 12 months
Not subject to Rili-BÄK
Parameters:
Detection of SARS-CoV-2 antigen
Certificate Validity: 12 months
Shipping Information:
Shipping not cooled
Safety Information:
Process as patient sample material
Dates:
Registration deadline:
Sample shipment:
Closing Date:
| Mar. (2) | June (4) | Sep. (5) | Nov. (6) |
|---|---|---|---|
| 08.01.2027 | 09.04.2027 | 25.06.2027 | 03.09.2027 |
| 09.03.2027 | 08.06.2027 | 24.08.2027 | 02.11.2027 |
| 26.03.2027 | 25.06.2027 | 10.09.2027 | 19.11.2027 |
EQAS/PT Experts:
Dr. med. Martin Obermeier
MVZ medizinisches Infektiologiezentrum Berlin AG
Oudenarder Strasse 16
13347 Berlin
+49 30-34409104-66
obermeier@mvz-mib.de
Dr. rer. nat. Martin Kammel
Institut für Qualitätssicherung in der Virusdiagnostik - IQVD
Potsdamer Chaussee 80
14129 Berlin
+49 30 8105 4300
m.kammel@iqvd.de
